Labiotech.eu

News and Trends 22 Jun 2022

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Belgian headquartered biotech Galapagos NV has acquired CellPoint and AboundBio, a move the Belgian company said propels it into next-generation cell therapy. Galapagos said the acquisitions give it access to an innovative, scalable, decentralized and automated point-of-care cell therapy supply model as well as a next-generation fully human antibody-based therapeutics platform. Galapagos said the goal […]

June 22, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Drug to treat esophageal cancer approved in China

A new drug application for first-line treatment of unresectable, locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) has been approved in China. Biopharmaceutical company Innovent Biologics Inc together with Eli Lilly and Company were jointly granted the approval for the supplemental new drug application for TYVYT, a sintilimab injection, combined with cisplatin plus […]

June 21, 2022 - 2 minutesmins - By Liza Laws

News and Trends 21 Jun 2022

New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer

Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an early predictor of tumor recurrence in patients who have had breast cancer. Liquid biopsy company Inivata announced the new data in support of its new RaDaR assay for the detection of MRD in those with high-risk hormone receptor-positive (HR+), human […]

June 21, 2022 - 3 minutesmins - By Liza Laws

News and Trends 21 Jun 2022

Treatment for highly-sensitized kidney transplant patients approved and recommended

Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney transplants from deceased donors has been recommended by the UK’s National Institute for Health and Care Excellence (NICE). NICE considers Idefirix (imlifidase), made by Hansa, a Swedish company that specializes in enzyme technology for rare immunological conditions, to be a […]

June 21, 2022 - 3 minutesmins - By Liza Laws

News and Trends 21 Jun 2022

Therorna funding to accelerate circRNA-based platform

Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based new vaccines and therapies, including for COVID-19, has completed a $42 million series A financing round. The funding was co-led by MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health Investment, and existing investors Quan Capital and Cenova Capital. […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Elypta raises $21M to develop early detection test for all cancers

Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early detection of any cancer, has raised $21 million in a series A financing round led by Bonnier Ventures. “The series A is a pivotal moment for Elypta as it fully funds the development of our two leading indications,” said Karl […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

conveyor belt of medical vials for scale up production

News and Trends 21 Jun 2022

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies

Indian biotech start-up Immuneel Therapeutics has announced it has started patient dosing in a CAR-T trial named “IMAGINE.” The Indian company focuses on creating access to Chimeric Antigen Receptor T cell therapy (CAR-T) and other cellular immunotherapies for the management and treatment of cancers. The phase II trial is the first industry sponsored CAR-T trial […]

June 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Biotalys and Novozymes partner on biofungicide

Belgian agtech company Biotalys and Danish biotech company Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol product. Novozymes will explore additional routes for the upscaling and production of the bioactive protein of Evoca, with the option of a possible commercial collaboration for a future generation of the product. […]

June 21, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Elektrofi raises $40M to develop drug formulation and delivery pipeline

Boston, U.S.-based biotech Elektrofi has completed a $40 million series B funding round. The company, which focuses on drug formulation and delivery, will use a portion of the proceeds to establish a centralized manufacturing line to support multiple upcoming clinical trials. The company also aims to double staff numbers over the next 12-18 months to […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

New agreement could lead to first African-owned COVID-19 vaccine

A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies – Afrigen Biologics and the Univercells Group – are set to work together. The agreement intends to pave the way for the development of the first African-owned COVID-19 vaccine. The collaboration will focus on the development of a novel mRNA […]

June 21, 2022 - 4 minutesmins - By Jim Cornall

stem cells, stem cell technology, lab-grown meat

News and Trends 21 Jun 2022

Aussie uni develops new 3D printing solution for stem cell manufacturing

Researchers at the University of Technology Sydney (UTS), Australia, have developed a 3D printed system for harvesting stem cells from bioreactors. The scientists said this could lead to high quality, wide-scale production of stem cells in Australia at a lower cost. Stem cells offer great promise in the treatment of many diseases and injuries, from […]

June 21, 2022 - 2 minutesmins - By Jim Cornall

Inside Labiotech 21 Jun 2022

How you can get involved in helping the industry–academia community solve global challenges

IN-PART’s ‘Global Challenge’ campaigns were born out of the response to COVID-19 in March 2020. As the impacts of the pandemic began to take hold, IN-PART recognized its position at the interface of industry and academia and its responsibility to leverage its networks to generate solutions to the unfolding crisis. Through online matchmaking platforms, IN-PART […]

June 21, 2022 - 3 minutesmins - By External Contributor

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Drug to treat esophageal cancer approved in China

New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer

Treatment for highly-sensitized kidney transplant patients approved and recommended

Therorna funding to accelerate circRNA-based platform

Elypta raises $21M to develop early detection test for all cancers

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies

Biotalys and Novozymes partner on biofungicide

Elektrofi raises $40M to develop drug formulation and delivery pipeline

New agreement could lead to first African-owned COVID-19 vaccine

Aussie uni develops new 3D printing solution for stem cell manufacturing

How you can get involved in helping the industry–academia community solve global challenges

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!